Metropolitan Life Insurance Company (MetLife)’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,985
| Closed | -$1.18M | – | 2121 |
|
|
2024
Q1 | $1.18M | Sell |
2,985
-27
| -0.9% | -$9.99K | 0.05% | 301 |
|
|
2023
Q4 | $1.06M | Sell |
3,012
-45
| -1% | -$15.9K | 0.05% | 307 |
|
|
2023
Q3 | $1.15M | Sell |
3,057
-179
| -6% | -$69.2K | 0.06% | 276 |
|
|
2023
Q2 | $1.24M | Sell |
3,236
-76
| -2% | -$27.1K | 0.06% | 283 |
|
|
2023
Q1 | $1.15M | Sell |
3,312
-970
| -23% | -$283K | 0.06% | 298 |
|
|
2022
Q4 | $1.01M | Buy |
4,282
+30
| +0.7% | +$7.11K | 0.05% | 366 |
|
|
2022
Q3 | $1.05M | Sell |
4,252
-54
| -1% | -$16.5K | 0.05% | 347 |
|
|
2022
Q2 | $1.3M | Sell |
4,306
-111
| -3% | -$36.1K | 0.06% | 308 |
|
|
2022
Q1 | $1.81M | Sell |
4,417
-7,310
| -62% | -$2.86M | 0.06% | 284 |
|
|
2021
Q4 | $5.5M | Sell |
11,727
-270
| -2% | -$116K | 0.07% | 208 |
|
|
2021
Q3 | $5.09M | Sell |
11,997
-383
| -3% | -$161K | 0.07% | 210 |
|
|
2021
Q2 | $4.45M | Sell |
12,380
-424
| -3% | -$140K | 0.06% | 248 |
|
|
2021
Q1 | $3.61M | Sell |
12,804
-726
| -5% | -$208K | 0.05% | 295 |
|
|
2020
Q4 | $3.83M | Sell |
13,530
-526
| -4% | -$148K | 0.06% | 265 |
|
|
2020
Q3 | $3.86M | Sell |
14,056
-542
| -4% | -$143K | 0.07% | 233 |
|
|
2020
Q2 | $3.32M | Sell |
14,598
-7,626
| -34% | -$1.5M | 0.06% | 266 |
|
|
2020
Q1 | $3.38M | Sell |
22,224
-1,192
| -5% | -$183K | 0.07% | 233 |
|
|
2019
Q4 | $3.52M | Buy |
23,416
+108
| +0.5% | +$15.7K | 0.06% | 298 |
|
|
2019
Q3 | $3.31M | Buy |
23,308
+1,472
| +7% | +$203K | 0.06% | 297 |
|
|
2019
Q2 | $2.73M | Sell |
21,836
-207
| -0.9% | -$24.4K | 0.05% | 363 |
|
|
2019
Q1 | $2.43M | Sell |
22,043
-26
| -0.1% | -$2.7K | 0.04% | 390 |
|
|
2018
Q4 | $2.16M | Buy |
22,069
+199
| +0.9% | +$21.6K | 0.04% | 382 |
|
|
2018
Q3 | $2.7M | Sell |
21,870
-214
| -1% | -$24K | 0.05% | 366 |
|
|
2018
Q2 | $2.19M | Sell |
22,084
-2,601
| -11% | -$239K | 0.04% | 464 |
|
|
2018
Q1 | $2.18M | Buy |
24,685
+88
| +0.4% | +$8.23K | 0.03% | 483 |
|
|
2017
Q4 | $2.43M | Sell |
24,597
-48,330
| -66% | -$4.74M | 0.03% | 432 |
|
|
2017
Q3 | $7.02M | Buy |
72,927
+459
| +0.6% | +$41.5K | 0.04% | 374 |
|
|
2017
Q2 | $6.85M | Buy |
72,468
+1,361
| +2% | +$125K | 0.05% | 391 |
|
|
2017
Q1 | $5.8M | Sell |
71,107
-108
| -0.2% | -$9.03K | 0.04% | 494 |
|
|
2016
Q4 | $6.04M | Sell |
71,215
-467
| -0.7% | -$36.7K | 0.04% | 447 |
|
|
2016
Q3 | $5.34M | Sell |
71,682
-201
| -0.3% | -$16K | 0.04% | 490 |
|
|
2016
Q2 | $5.45M | Sell |
71,883
-43,312
| -38% | -$3.15M | 0.04% | 474 |
|
|
2016
Q1 | $7.99M | Buy |
115,195
+3,524
| +3% | +$212K | 0.06% | 299 |
|
|
2015
Q4 | $6.72M | Buy |
111,671
+1,061
| +1% | +$63.8K | 0.05% | 351 |
|
|
2015
Q3 | $5.99M | Buy |
110,610
+60,675
| +122% | +$3.54M | 0.04% | 417 |
|
|
2015
Q2 | $2.9M | Sell |
49,935
-4,473
| -8% | -$250K | 0.02% | 799 |
|
|
2015
Q1 | $3.28M | Buy |
54,408
+1,136
| +2% | +$60.5K | 0.02% | 708 |
|
|
2014
Q4 | $2.84M | Sell |
53,272
-1,191
| -2% | -$59.6K | 0.02% | 810 |
|
|
2014
Q3 | $2.44M | Sell |
54,463
-899
| -2% | -$38.2K | 0.02% | 865 |
|
|
2014
Q2 | $2.33M | Sell |
55,362
-237
| -0.4% | -$10.2K | 0.02% | 933 |
|
|
2014
Q1 | $2.45M | Hold |
55,599
| – | – | 0.02% | 876 |
|
|
2013
Q4 | $2.73M | Buy |
55,599
+145
| +0.3% | +$6.79K | 0.02% | 807 |
|
|
2013
Q3 | $2.28M | Buy |
55,454
+1,188
| +2% | +$45.3K | 0.02% | 861 |
|
|
2013
Q2 | $1.91M | Buy |
+54,266
| New | +$1.79M | 0.02% | 907 |
|
Other funds holding WST
Metropolitan Life Insurance Company (MetLife)'s WST Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 2,985 shares — an estimated $1.18M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in WST in Q2 2013 and held it in 44 quarters. The position peaked at $7.99M in Q1 2016. 777 funds tracked by Wall St. Rank hold WST as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,985 West Pharmaceutical shares in Q2 2024, an estimated $1.18M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in West Pharmaceutical in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s West Pharmaceutical position peaked at $7.99M in Q1 2016.
- 777 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.